Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 7/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | SCN1A | P35498 | 1/20 | 0.42 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL178207 | 0.84 | KCNA5 (0.51) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL15706913 | 0.83 | SLC6A2 (0.45) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL506917 | 0.81 | KCNA5 (0.52) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL29767197 | 0.81 | KCNA5 (0.52) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL31744336 | 0.81 | KCNA5 (0.52) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL7268370 | 0.81 | KCNA5 (0.52) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL28588502 | 0.81 | SLC6A2 (0.47) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL28454017 | 0.80 | KCNA5 (0.47) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL30887852 | 0.79 | KCNA5 (0.50) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL65284 | 0.78 | TSHR (0.62) | KCNA5KCNH2CYP1A2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101018797-A | Preparation of platinum (II) complexes | PLATCO TECHNOLOGIES PROPRIETAR (ZA) | 2007-08-15 | — | — | CN | claimed |
| EP-2390243-B1 | PROCESS FOR PREPARING BISPHENOL | MITSUBISHI CHEM CORP (JP) | 2020-07-08 | — | — | EP | disclosed |
| US-8445731-B2 | Process for producing bisphenol compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-05-21 | — | — | US | disclosed |
| US-20120010434-A1 | PROCESS FOR PRODUCING BISPHENOL COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-01-12 | — | — | US | disclosed |
| EP-2390243-A1 | PROCESS FOR PREPARING BISPHENOL | Mitsubishi Chemical Corporation (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110256982-A1 | INTERLOCK CIRCUIT FOR UTILITY VEHICLE PARK BRAKE | DEERE & COMPANY | 2011-10-20 | — | — | US | disclosed |
| CN-101018797-A | Preparation of platinum (II) complexes | PLATCO TECHNOLOGIES PROPRIETAR (ZA) | 2007-08-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010434-A1 | PROCESS FOR PRODUCING BISPHENOL COMPOUND | SULT2A1, SULT1A1, PLPBP | KCNA5 3451/4885KCNH2 2185/4885CYP1A2 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.